Cargando…
Cost-effectiveness of Maintenance Therapy Based on Molecular Classification Following Treatment of Primary Epithelial Ovarian Cancer in the United States
IMPORTANCE: There are large randomized clinical trials—SOLO-1 (Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy [December 2018]), PRIMA (A Study of Niraparib Maintenance Treatment in Patients With Advanced Ovarian Cancer F...
Autores principales: | Penn, Courtney A., Wong, Melissa S., Walsh, Christine S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726632/ https://www.ncbi.nlm.nih.gov/pubmed/33295974 http://dx.doi.org/10.1001/jamanetworkopen.2020.28620 |
Ejemplares similares
-
Cost-effectiveness of hyperthermic intraperitoneal chemotherapy at primary cytoreduction of epithelial ovarian cancer based on residual disease status
por: Penn, Courtney A., et al.
Publicado: (2022) -
Cost-effectiveness of Population-Wide Genomic Screening for Hereditary Breast and Ovarian Cancer in the United States
por: Guzauskas, Gregory F., et al.
Publicado: (2020) -
Cost-Effectiveness of Pharmacist Prescribing for Managing Hypertension in the United States
por: Dixon, Dave L., et al.
Publicado: (2023) -
Evaluation of Amphetamine-Related Hospitalizations and Associated Clinical Outcomes and Costs in the United States
por: Winkelman, Tyler N. A., et al.
Publicado: (2018) -
Cost-effectiveness of Universal and Targeted Hepatitis C Virus Screening in the United States
por: Tatar, Moosa, et al.
Publicado: (2020)